Views

Using Real World Data to Guide Precision Oncology Drug Development
Precision medicine is the commitment to deliver the right therapy to the right patient at the right time. This is a challenging goal, especially in oncology, given the wide diversity of diseases and patients. To address the challenges, drug developers are increasingly analyzing real world data (RWD) to generate real-world evidence (RWE) to complement what can be learned from traditional randomized, controlled clinical trials (RCTs).
View Nov 25, 2024